The United States Blood Bank Reagents Market size is reached a valuation of USD xx.x Billion in 2023, with projections to achieve USD xx.x Billion by 2031, demonstrating a compound annual growth rate (CAGR) of xx.x% from 2024 to 2031.
United States Blood Bank Reagents Market By Application
- Blood Typing
- Antibody Detection
- Compatibility Testing
- Infectious Disease Screening
- Other Applications
The United States blood bank reagents market is segmented by application into several key areas. Blood typing, a critical component of blood transfusion services, involves the use of reagents to determine the blood group (A, B, AB, O) and Rh factor (positive or negative). Antibody detection assays are utilized to identify irregular antibodies in patient sera, crucial for assessing compatibility between donor and recipient blood. Compatibility testing reagents ensure safe transfusion by confirming compatibility between donor and recipient blood samples before transfusion.
Infectious disease screening reagents are vital for detecting pathogens such as HIV, hepatitis B and C, and other transfusion-transmitted infections in donated blood. These tests enhance the safety of the blood supply by preventing the transmission of infectious diseases. Other applications of blood bank reagents include reagents used in direct antiglobulin testing (DAT) and cross-matching procedures to ensure safe and effective blood transfusions. The demand for these reagents is driven by the increasing number of blood transfusions and stringent regulatory requirements for blood safety in the United States.